|
Eckert & Ziegler SE / Key word(s): Half Year Results/Change in Forecast Eckert & Ziegler Again Increases Sales and Earnings Compared to Previous Year. Profit Forecast Raised for 2024. 16-Jul-2024 / 14:26 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News – a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. 2nd quarter of 2024:
1st half of 2024:
Forecast for 2024:
Berlin, July 16, 2024. According to preliminary calculations, Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) generated sales of EUR 145.4 million in the first half of 2024 (previous year: EUR 118.0 million). The key figure EBIT before special items, introduced as part of the 2024 forecast, amounted to EUR 32.5 million in the first half of 2024 (previous year: EUR 22.6 million). Net profit, which is only reported here on a comparative basis, increased to EUR 18.0 million (previous year: EUR 10.9 million). The Executive Board is raising its profit forecast for the current financial year and expects EBIT before special items of around EUR 55 million. The sales forecast for the current financial year 2024 published on March 22, 2024 remains unchanged. The Executive Board continues to expect sales of just under EUR 265 million.The full figures for the first half of 2024 will be published on August 9, 2024. Contact: End of Inside Information 16-Jul-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Pα+ Psychedelic Bulletin #165: A Closer Look at a Buzzy Oral Ketamine for Depression Study; UN Weighs In on Psychedelics; Another CA Psychedelics Bill Fails – Psychedelic Alpha
In this Issue Phase 2 Study of Oral Ketamine for Depression Lauded by Media and Sponsor, Yet Closer Look Reveals Underwhelming Results UN World Drug
June 28, 2024